We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

202 hedge funds and large institutions have $952M invested in BioTelemetry, Inc. in 2018 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 80 increasing their positions, 61 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 27

31% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 61

28% more call options, than puts

Call options by funds: $10.3M | Put options by funds: $8.07M

11% more capital invested

Capital invested by funds: $856M → $952M (+$96.2M)

5% more funds holding

Funds holding: 192202 (+10)

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
202
Holders Change
+10
Holders Change %
+5.21%
% of All Funds
4.63%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
38
Increased
80
Reduced
61
Closed
27
Calls
$10.3M
Puts
$8.07M
Net Calls
+$2.25M
Net Calls Change
+$3.17M
Name Holding Trade Value Shares
Change
Change in
Stake
SO
51
STRS Ohio
Ohio
$3.42M -$921K -28,000 -20%
Deutsche Bank
52
Deutsche Bank
Germany
$3.11M +$990K +30,119 +43%
AIC
53
AWM Investment Company
New York
$3.08M
GF
54
Gabelli Funds
New York
$3.04M
JP Morgan Chase
55
JP Morgan Chase
New York
$2.98M +$2.2M +67,002 +231%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$2.97M -$223K -6,786 -7%
Goldman Sachs
57
Goldman Sachs
New York
$2.79M +$335K +10,191 +13%
UBS Group
58
UBS Group
Switzerland
$2.68M -$78.6K -2,390 -3%
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
$2.61M +$194K +5,886 +8%
DIA
60
Dana Investment Advisors
Wisconsin
$2.45M +$10.4K +317 +0.4%
Millennium Management
61
Millennium Management
New York
$2.42M +$2.57M +78,042 New
RJA
62
Raymond James & Associates
Florida
$2.37M +$1M +30,492 +66%
HSA
63
Hussman Strategic Advisors
Maryland
$2.33M +$2.47M +75,000 New
TCIM
64
TIAA CREF Investment Management
New York
$2.28M -$3.13M -95,118 -56%
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$2.26M +$104K +3,173 +5%
DCM
66
DAFNA Capital Management
California
$2.16M -$612K -18,600 -21%
PCM
67
Prelude Capital Management
New York
$2.05M +$95.6K +2,908 +5%
RJFSA
68
Raymond James Financial Services Advisors
Florida
$2.02M +$1.17M +35,558 +121%
TA
69
Teachers Advisors
New York
$1.98M +$160K +4,878 +8%
Legal & General Group
70
Legal & General Group
United Kingdom
$1.78M +$54.4K +1,653 +3%
VRS
71
Virginia Retirement Systems
Virginia
$1.68M -$6.58K -200 -0.4%
Point72 Asset Management
72
Point72 Asset Management
Connecticut
$1.67M +$1.77M +53,900 New
Swiss National Bank
73
Swiss National Bank
Switzerland
$1.66M +$92.1K +2,800 +6%
Prudential Financial
74
Prudential Financial
New Jersey
$1.62M +$47.7K +1,450 +3%
CPIM
75
Columbia Partners Investment Management
Virginia
$1.61M -$628K -19,089 -27%

BEAT Hedge Fund Activity: Q1 2018 in Review

202 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q1 2018, worth a combined $952M — up 11% from $856M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new BEAT positions and 27 closed out — a net gain of 11 holders — while 80 added to existing stakes and 61 trimmed.

The largest buyer was Credit Suisse, adding an estimated $21M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $16.8M sold.

  • 202 institutional investors held BioTelemetry, Inc. (BEAT) as of Q1 2018, up from 192 in Q4 2017.
  • Funds reported $952M of BioTelemetry, Inc. stock for Q1 2018, up 11% quarter-over-quarter.
  • 38 funds opened new BioTelemetry, Inc. positions in Q1 2018 and 27 closed out, a net change of +11 holders.
  • The largest BioTelemetry, Inc. buyer in Q1 2018 was Credit Suisse, an estimated $21M added.
  • The largest BioTelemetry, Inc. seller in Q1 2018 was Renaissance Technologies, an estimated $16.8M sold.

Based on aggregated 13F filings for Q1 2018.